Breast Cancer and Depression: A Scoping Review of Indian Literature

Objective: To explore depression prevalence, correlates, impact, and interventions in breast cancer patients, with a focus on the Indian context.

Data Sources: The search specifically targeted PubMed as the primary electronic database using keywords such as breast cancer, depression, and India. No date limits were imposed, and studies were restricted to those available in English.

Study Selection: A total of 12 studies were reviewed, comprising original research articles and case studies. Inclusion criteria encompassed studies investigating depression in breast cancer patients, irrespective of study design or intervention type.

Data Extraction: Data abstraction followed predefined guidelines, focusing on depression prevalence rates, factors associated with depression onset, intervention efficacy, and implications for clinical practice. Data were extracted independently by 2 reviewers, with discrepancies resolved through discussion.

Data Synthesis: Findings revealed diverse depression rates among breast cancer patients, ranging from 21.5% to 83.5%. Treatment type, body image concerns postsurgery, stigma, and sociodemographic factors such as low income, education, and rural residency were identified as contributors to depression onset. Nonpharmacologic interventions, particularly yoga and supportive psychotherapy, demonstrated efficacy in mitigating depression symptoms.

Conclusions: This review underscores the multifaceted nature of depression in breast cancer patients and the importance of tailored interventions to address this psychological comorbidity. Integration of mental health services into cancer care frameworks, alongside traditional treatment modalities, is essential to ensure comprehensive support for breast cancer patients. The findings advocate for a holistic approach to mental health within cancer care, emphasizing the need for policy initiatives that prioritize psychosocial well being alongside physical health outcomes.

Prim Care Companion CNS Disord 2024;26(5):24r03721.

Author affiliations are listed at the end of this article.